Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients

    ... with location of treatment (community or academic), prognostic risk category, and patient age. METHODS: The adults in ... (supportive, active, and transplant) were stratified by the international prognostic scoring system (IPSS) and the revised-IPSS (IPSS-R), ...

    Research Article last updated 03/03/2015 - 12:54pm.

  2. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

    ... 3, MDS-004 study to evaluate outcomes in patients with International Prognostic Scoring System (IPSS)-defined Low-/Intermediate (Int)-1-risk ...

    Research Article last updated 07/29/2014 - 12:12pm.

  3. How we treat higher-risk myelodysplastic syndromes

    ... higher risk group categories in the original or revised International Prognostic Scoring System (IPSS). Survival for these patients is dismal, ...

    Research Article last updated 01/08/2014 - 8:57am.

  4. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    ... characteristics. The most commonly used system is the International Prognostic Scoring System (IPSS). IPSS is likely to be replaced by a new ...

    Research Article last updated 02/04/2014 - 1:37pm.

  5. A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes

    ... Tie2, was conducted in patients with low or intermediate-1 International Prognostic Scoring System risk MDS to evaluate safety, pharmacokinetics (PK), ...

    Research Article last updated 01/20/2015 - 1:07pm.

  6. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management

    ... characteristics. The most commonly used system is the International Prognostic Scoring System . IPSS is likely to be replaced by a new revised ...

    Research Article last updated 07/31/2012 - 2:02pm.

  7. Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes

    ... independence in low and intermediate-1 risk International Prognostic Scoring System (IPSS) del(5q) myelodysplastic syndromes ...

    Research Article last updated 11/05/2012 - 9:37am.

  8. Prognosis of myelodysplastic syndromes.

    ... as peripheral cytopenias and cytogenetics . The International Prognostic Scoring System (IPSS) is a classic example of this type of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion

    ... leukaemia (AML) progression in 215 patients with International Prognostic Scoring System (IPSS) low or intermediate-1 risk and del(5q). ...

    Research Article last updated 07/29/2014 - 12:11pm.

  10. Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

    ... MDS patients, especially those classified as International Prognostic Scoring System (IPSS) Low or Intermediate-1 (Low/Int-1). ...

    Research Article last updated 07/29/2014 - 12:11pm.